phosphatidylcholines has been researched along with Fungal Lung Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunson, ME; Duchini, A; McHutchison, JG; Pockros, PJ; Redfield, DC | 1 |
| Alexander, D; Crompton, JA; Shihab, FS; Somerville, T | 1 |
| Chandrasekar, PH; Hooshmand-Rad, R; Ito, JI | 1 |
| Bahna, P; Hachem, R; Hanna, H; Raad, I; Stephens, LC | 1 |
| Adler-Moore, JP; Jensen, GM; Olson, JA; Proffitt, RT; Schwartz, J | 1 |
| Edwards, JE; Fu, Y; Ibrahim, AS; Rieg, G; Schwartz, J; Sheppard, DC; Spellberg, B | 1 |
| Frank, M; Jaradeh, SS; Ortega-Gutierrez, S; Szeder, V | 1 |
| Cappelli, B; Castagnola, E; Cuzzubbo, D; Faraci, M; Lanino, E; Moresco, L; Moroni, C | 1 |
| Armstrong, D; Bernard, EM; Cicogna, CE; Ishimura, T; Sun, M; Tong, WP; White, MH | 1 |
| Arney, KL; Judson, MA; Tiernan, R | 1 |
| Kyi, AA; Myint, H; Winn, RM | 1 |
1 review(s) available for phosphatidylcholines and Fungal Lung Diseases
| Article | Year |
|---|---|
Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Combinations; Female; Humans; Inguinal Canal; Itraconazole; Liver Transplantation; Lung; Lung Diseases, Fungal; Lymphatic Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Survival Rate | 2002 |
1 trial(s) available for phosphatidylcholines and Fungal Lung Diseases
| Article | Year |
|---|---|
An open, non-comparative evaluation of the efficacy and safety of amphotericin B lipid complex as treatment of neutropenic patients with presumed or confirmed pulmonary fungal infections.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Humans; Hypokalemia; Lung; Lung Diseases, Fungal; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 1998 |
9 other study(ies) available for phosphatidylcholines and Fungal Lung Diseases
| Article | Year |
|---|---|
Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
Topics: Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 2004 |
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Child; Child, Preschool; Databases, Factual; Drug Combinations; Drug Evaluation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2005 |
EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcium; Colony Count, Microbial; Confidence Intervals; Creatinine; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edetic Acid; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Survival Analysis; Time Factors | 2006 |
Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Topics: Administration, Inhalation; Aerosols; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blood Urea Nitrogen; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Kidney Tubules; Liposomes; Lung Diseases, Fungal; Mice; Mice, Inbred DBA; Phosphatidylcholines; Phosphatidylglycerols; Survival Analysis; Time Factors | 2006 |
Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Drug Combinations; Injections, Intravenous; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Time Factors | 2006 |
CNS blastomycosis in a young man working in fields after Hurricane Katrina.
Topics: Adult; Agricultural Workers' Diseases; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Brain; Cognition Disorders; Contrast Media; Deoxycholic Acid; Disasters; Drug Combinations; Encephalitis; Facial Dermatoses; Gadolinium; Humans; Itraconazole; Louisiana; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Phosphatidylcholines; Phosphatidylglycerols; Skin Ulcer | 2007 |
Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Lung Diseases, Fungal; Mitochondrial Diseases; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Syndrome; Transplantation, Homologous | 2007 |
Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.
Topics: Aerosols; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Combinations; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley | 1997 |
Primary pulmonary involvement of Fusarium solani in a lung transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fusarium; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Soil Microbiology | 1997 |